Average Ratings 0 Ratings
Average Ratings 1 Rating
Description
OKRA.ai is revolutionizing the Life Sciences sector by harnessing the power of advanced intelligence. By enhancing operations in medical, commercial, and market access, OKRA.ai is reshaping how the pharmaceutical industry functions. Discover how you can leverage your own AI capabilities to achieve cost-effective solutions, streamline processes, and focus on specific patient outcomes within your organization. With OKRA’s MarketSphere, you can utilize top-tier AI technology that transforms insights into actionable intelligence and supports your strategic decisions. Experience foresight with predictions extending up to a year ahead, enabling you to launch new products, reallocate resources, or make informed investments for maximum returns. This approach works across all brands and regions. Additionally, for medical leaders, MedCompass provides valuable insights into the unmet needs and sentiments of the community, including key opinion leaders (KOLs) and healthcare professionals (HCPs), across various markets and therapeutic areas. This transition to a more dynamic and comprehensive understanding of topic evolution over time can significantly enhance strategic planning and decision-making. By embracing these innovative tools, organizations can better adapt to the rapidly changing landscape of the pharmaceutical industry.
Description
konectar is an AI-powered KOL Management platform designed to solve one of the most persistent challenges in life sciences: knowing which healthcare professionals truly matter for your strategy, and how to engage them effectively.
Most KOL management approaches rely on manual research, internal nominations, or relationships inherited from predecessor teams. konectar replaces that patchwork with a structured, AI-powered intelligence layer, one that continuously analyses scientific output, clinical trial involvement, conference activity, peer networks, and digital presence to rank and profile HCPs across any therapeutic area.
The result is a platform that helps medical affairs and commercial teams move faster, engage more credibly, and build relationships that are rooted in scientific alignment rather than proximity or habit.
Key Features
* Rank and map KOLs across global, national, and regional levels with comprehensive 360-degree profiles.
* Real-time profile updates as HCPs publish, present, and participate in trials
* Conference monitoring and planning effective participation, conference intelligence with pre- and post-congress reports
* Social listening and DOL tracking via konectar Social
* Driving effective engagement with konectar CRM
konectar is used by pharma, biotech, and medtech teams across all company sizes and geographies.
API Access
Has API
No
API Access
Has API
No
Integrations
Amazon Web Services (AWS)
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
$0
We can have a meeting to discuss the same.
Free Trial
Yes
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
Yes
Online Support
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
OKRA.ai
Founded
2015
Country
United Kingdom
Website
okra.ai/
Vendor Details
Company Name
Aissel Technologies
Founded
2010
Country
United States
Website
www.aissel.com
Product Features
Artificial Intelligence
Chatbot
No
For Healthcare
No
For Sales
No
For eCommerce
No
Image Recognition
No
Machine Learning
No
Multi-Language
No
Natural Language Processing
No
Predictive Analytics
No
Process/Workflow Automation
No
Rules-Based Automation
No
Virtual Personal Assistant (VPA)
No